Alzheimer's Disease
Showing 26 - 50 of 955
Alzheimer's Disease Trial in Kansas City (Creatine Monohydrate)
Recruiting
- Alzheimer's Disease
- Creatine Monohydrate
-
Kansas City, KansasUniversity of Kansas Medical Center
Jan 9, 2023
Tau PET/CT Imaging in Mismatch Prospective Cohort Study
Recruiting
- Alzheimer's Disease
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jan 6, 2023
Alzheimer's Disease Trial in Heidelberg, Shepparton, West Perth (SLS-005, Placebo)
Not yet recruiting
- Alzheimer's Disease
- SLS-005
- Placebo
-
Heidelberg, Victoria, Australia
- +2 more
Dec 23, 2022
Alzheimer's Disease, Mild Cognitive Impairment Trial in Irvine, Los Angeles (Nicotinamide, Placebo Comparator)
Completed
- Alzheimer's Disease
- Mild Cognitive Impairment
- Nicotinamide
- Placebo Comparator
-
Irvine, California
- +1 more
Dec 14, 2022
Alzheimer's Disease Trial in United States (Hydroxypropyl Beta Cyclodextrin, Placebo)
Recruiting
- Alzheimer's Disease
- Hydroxypropyl Beta Cyclodextrin
- Placebo
-
Brooksville, Florida
- +4 more
Nov 22, 2022
Alzheimer's Disease Trial in Colombia (Crenezumab, Placebo)
Active, not recruiting
- Alzheimer's Disease
- Crenezumab
- Placebo
-
Armenia, Colombia
- +3 more
Nov 21, 2022
Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis
Recruiting
- Alzheimer's Disease
-
Beijing, Beijing, ChinaXuanwu Hospital of Capital Medical University
Nov 15, 2022
Alzheimer's Disease Trial in San Antonio (PU-AD, Placebo)
Completed
- Alzheimer's Disease
- PU-AD
- Placebo
-
San Antonio, TexasICON Early Phase Services
Nov 14, 2022
Alzheimer's Disease Trial in Worldwide (BIIB092, Placebo)
Alzheimer's Disease Trial in Worldwide (PF-04360365 0.1 mg/kg, PF-04360365 0.5 mg/kg, PF-04360365 1 mg/kg)
Completed
- Alzheimer's Disease
- PF-04360365 0.1 mg/kg
- +5 more
-
Peoria, Arizona
- +41 more
Oct 11, 2022
Mild Cognitive Impairment, Alzheimer's Disease Trial in New York (Lighting Intervention Therapy, Sham LIT)
Recruiting
- Mild Cognitive Impairment
- Alzheimer's Disease
- Lighting Intervention Therapy
- Sham LIT
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Oct 25, 2022
BEAM: Brain-Eye Amyloid Memory Study
Recruiting
- Alzheimer's Disease
- +4 more
- Pittsburgh Compound B [11C]-PIB
-
Toronto, Ontario, Canada
- +4 more
Oct 24, 2022
Mild Cognitive Impairment, Alzheimer's Disease Trial (Centella asiatica product, Placebo)
Not yet recruiting
- Mild Cognitive Impairment
- Alzheimer's Disease
- Centella asiatica product
- Placebo
- (no location specified)
Oct 18, 2022
Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)
Active, not recruiting
- Alzheimer's Disease
- Semorinemab
- +2 more
-
Garden Grove, California
- +48 more
Sep 1, 2022
Alzheimer's Disease, Dementia With Lewy Bodies, Frontotemporal Dementia Trial in Rochester (Pittsburgh Compound B (C-11 PiB),
Enrolling by invitation
- Alzheimer's Disease
- +3 more
- Pittsburgh Compound B (C-11 PiB)
- +2 more
-
Rochester, MinnesotaMayo Clinic
Sep 30, 2022
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia,
Recruiting
- Alzheimer's Disease
- +2 more
- DaTscan
- +5 more
-
Columbus, OhioThe Ohio State University
Sep 23, 2022
Alzheimer's Disease Trial in Israel, United Kingdom (IBC-Ab002, Placebo)
Not yet recruiting
- Alzheimer's Disease
- IBC-Ab002
- Placebo
-
Haifa, Israel
- +5 more
Sep 20, 2022
Alzheimer's Disease, Mild Cognitive Impairment Due to Alzheimer's Disease, Healthy Volunteers Trial in Wuhan ([18F]APN-1607)
Recruiting
- Alzheimer's Disease
- +2 more
-
Wuhan, Hubei, ChinaUnion Hospital Tongji Medical College Huazhong University of Sci
Sep 13, 2022
Alzheimer's Disease Trial in Baton Rouge (Healthy Lifestyle Program, Physical Activity Intervention)
Completed
- Alzheimer's Disease
- Healthy Lifestyle Program
- Physical Activity Intervention
-
Baton Rouge, Louisiana
- +1 more
Sep 13, 2022
Longitudinal Quantitative Susceptibility Mapping in Alzheimer 's
Enrolling by invitation
- Alzheimer's Disease
- MRI
- (no location specified)
Aug 24, 2022
Alzheimer's Disease Trial in Worldwide (Placebo, Bepranemab)
Recruiting
- Alzheimer's Disease
- Placebo
- Bepranemab
-
Sun City, Arizona
- +115 more
Aug 18, 2022
Alzheimer's Disease Trial in United States (Remternetug (IV), Remternetug (SC), Placebo)
Recruiting
- Alzheimer's Disease
- Remternetug (IV)
- +2 more
-
Chandler, Arizona
- +70 more
Aug 10, 2022
Alzheimer's Disease Trial in United States (Posiphen, Placebo)
Active, not recruiting
- Alzheimer's Disease
- Posiphen
- Placebo
-
La Jolla, California
- +5 more
Aug 1, 2022